Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia

Clin Infect Dis. 2014 Jun;58(12):1784-6. doi: 10.1093/cid/ciu169. Epub 2014 Mar 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Agammaglobulinemia / complications
  • Antiviral Agents / therapeutic use*
  • Chronic Disease
  • Common Variable Immunodeficiency / complications
  • Drug Therapy, Combination
  • Humans
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Picornaviridae Infections / complications
  • Picornaviridae Infections / drug therapy*
  • Picornaviridae Infections / virology
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Rhinovirus*
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a